Thu, August 11, 2022
Wed, August 10, 2022
Tue, August 9, 2022
Mon, August 8, 2022

Michael Ulz Maintained (XLO) at Buy with Decreased Target to $20 on, Aug 10th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-20-on-aug-10th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Michael Ulz of Morgan Stanley, Maintained "Xilio Therapeutics, Inc." (XLO) at Buy with Decreased Target from $32 to $20 on, Aug 10th, 2022.

Michael, nor any peers, have made any analyst calls on XLO in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Publication Contributing Sources